Developing a Randomised Efficacy PREcision medicine Platform trial design for Cavernomas: the CARE PREP study
Background Symptomatic cerebral cavernous malformations are a rare sporadic or familial disease, which may cause haemorrhagic strokes or epileptic seizures. In 2015, a James Lind Alliance Priority Setting Partnership ranked targeted drug therapies as fourth of the top 10 research priorities for cere...
Saved in:
| Main Authors: | Rustam Al-Shahi Salman, Kasia Adamczuk, Richard A Parker, Christopher J Weir, Roberto Latini, Helen Kim, David White, Helen Evans, Jana Bergholtz, Cornelia Lee, Carlos Casaus |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
NIHR Journals Library
2025-03-01
|
| Series: | Efficacy and Mechanism Evaluation |
| Subjects: | |
| Online Access: | https://doi.org/10.3310/TYUP6982 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCT
by: Rustam Al-Shahi Salman, et al.
Published: (2025-08-01) -
Propranolol: A Promising Therapeutic Avenue for Classic Kaposi Sarcoma
by: Rasha Mahmoud Genedy, et al.
Published: (2025-01-01) -
Extremely Extensive Vascular Malformation Requires Special Preparation for Simple Dental Surgical Procedures—Case Report
by: Natalia Muczkowska, et al.
Published: (2025-05-01) -
Management of Cavernous Haemangiomas
by: J.J. Kashalikar
Published: (1990-04-01) -
Current Approach to The Treatment of Infantile Hemangioma
by: Aybüke Doğan, et al.
Published: (2023-03-01)